Tiverton Asset Management’s Haemonetics HAE Stock Holding History

Tiverton Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$195K	Buy	+1,545	New	+$196K	0.01%	557

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Tiverton Asset Management's HAE Position: Q3 2019 in Review

Tiverton Asset Management opened a new position in Haemonetics (HAE) in Q3 2019: 1,545 shares worth $195K. The stake represents 0.01% of the portfolio and ranks #557 among its holdings.

275 funds tracked by Wall St. Rank hold HAE as of Q3 2019.

Tiverton Asset Management held 1,545 shares of Haemonetics worth $195K as of Q3 2019.
Haemonetics was a new Tiverton Asset Management position in Q3 2019.
Haemonetics made up 0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #557 holding.
275 funds tracked by Wall St. Rank held Haemonetics as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.